Clinical Stage 1 |
Clinical Stage 2 |
Clinical Stage 3 |
Clinical Stage 4 |
Acute retroviral infection |
Weight loss < 10 % body weight |
Weight loss > 10 % body weight |
Extrapulmonary Tuberculosis |
Asymptomatic |
Minor mucocutaneous manifestations |
Unexplained chronic diarrhoea >1 month |
Candida ‐ oesophagus, trachea or bronchi |
Persistent generalised lymphadenopathy |
Herpes Zoster, within the last 5 years |
Oral candidiasis |
Pneumocystis carinii pneumonia |
+/‐ performance scale 1 (asymptomatic, normal activity) |
Recurrent upper respiratory infections |
Vulvo‐vaginal candidiasis, chronic (> 1 month) |
Herpes simplex ‐ oral >1 month |
|
+/‐ performance scale 2 (symptomatic, normal activity) |
Oral hairy leukoplakia |
Herpes simplex‐ visceral, any duration |
|
|
Pulmonary Tuberculosis, within past year |
HIV wasting syndrome |
|
|
Severe bacterial infections |
Kaposi's sarcoma |
|
|
+/‐ performance scale 3 (bedridden < 50 % of the day) |
Toxoplasmosis of the brain |
|
|
|
Cryptococcosis, extrapulmonary |
|
|
|
HIV encephalopathy |
|
|
|
Non‐Typhoid Salmonella bacteraemia |
|
|
|
Cytomegalovirus infection |
|
|
|
Cryptosporidiosis‐diarrhoea > 1 month |
|
|
|
Progressive multifocal leuko‐encephalopathy |
|
|
|
Lymphoma |
|
|
|
Atypical mycobacteriosis, disseminated |
|
|
|
Any disseminated endemic mycosis |
|
|
|
performance scale 4 (bedridden > 50 % of last month) |
|
|
|
|
|
|
|
|